The litigation landscape

Notable litigation and licensing events culled from the BioCentury new archives.

Mar 1987 Eli Lilly filed suit against Genentech over hGH; Genentech sued Lilly in Nov. 1987
Oct 1987 Genetics Institute and Amgen sued each other over EPO
Feb 1988 Genetics Institute won its EPO suit against Amgen
Mar 1989 Genetics Institute, Genentech and Miles cross-licensed rights to Factor VIII
Apr 1990 Xoma sued Centocor over their sepsis antibodies
Mar 1991 U.S. Appeals court reversed Feb. 1998 decison, ruling in favor of Amgen in its EPO case against Genetics Institute, blocking Genetics Institute from the U.S. market